Cargando…
Mesenchymal Stem Cell Therapy for Alzheimer's Disease
Alzheimer's disease (AD) is a neurodegenerative disease responsible for 60-70% of the 50 million cases of dementia worldwide. It is characterized by neuronal cell death, shrinkage of brain tissue, and progressive cognitive, motor, and behavioral impairment, which often leads to death. Although...
Autores principales: | Hernández, A. E., García, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426054/ https://www.ncbi.nlm.nih.gov/pubmed/34512767 http://dx.doi.org/10.1155/2021/7834421 |
Ejemplares similares
-
Mesenchymal stem cell-derived exosome: a promising alternative in the therapy of Alzheimer’s disease
por: Guo, Mengtian, et al.
Publicado: (2020) -
Mesenchymal Stem Cell-Derived Extracellular Vesicle-Based Therapy for Alzheimer’s Disease: Progress and Opportunity
por: Chen, Yi-An, et al.
Publicado: (2021) -
Mesenchymal stem cell- and extracellular vesicle-based therapies for Alzheimer’s disease: progress, advantages, and challenges
por: Gonçalves, Renata Guedes de Jesus, et al.
Publicado: (2022) -
Stem cell therapy for Alzheimer's disease
por: Liu, Xin-Yu, et al.
Publicado: (2020) -
Alzheimer's Disease and Stem Cell Therapy
por: Choi, Sung S., et al.
Publicado: (2014)